These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 7845889)

  • 21. Peroxisomal fatty acid beta-oxidation in relation to adrenoleukodystrophy.
    Wanders RJ; Tager JM
    Dev Neurosci; 1991; 13(4-5):262-6. PubMed ID: 1817031
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of pharmacological induction of fatty acid beta-oxidation in X-linked adrenoleukodystrophy.
    McGuinness MC; Zhang HP; Smith KD
    Mol Genet Metab; 2001; 74(1-2):256-63. PubMed ID: 11592822
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Peroxisomal very long chain fatty acid beta-oxidation activity is determined by the level of adrenodeukodystrophy protein (ALDP) expression.
    Braiterman LT; Watkins PA; Moser AB; Smith KD
    Mol Genet Metab; 1999 Feb; 66(2):91-9. PubMed ID: 10068511
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lignoceroyl-CoASH ligase: enzyme defect in fatty acid beta-oxidation system in X-linked childhood adrenoleukodystrophy.
    Hashmi M; Stanley W; Singh I
    FEBS Lett; 1986 Feb; 196(2):247-50. PubMed ID: 3948997
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunochemical and biochemical studies of fatty acid oxidation in fibroblasts of Zellweger and X-linked adrenoleukodystrophy patients.
    Reubsaet FA; Veerkamp JH; Brückwilder ML; Trijbels JM; Hashimoto T; Monnens LA
    Biochim Biophys Acta; 1991 Jun; 1083(3):305-9. PubMed ID: 2049396
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Accumulation and defective beta-oxidation of very long chain fatty acids in Zellweger's syndrome, adrenoleukodystrophy and Refsum's disease variants.
    Poulos A; Singh H; Paton B; Sharp P; Derwas N
    Clin Genet; 1986 May; 29(5):397-408. PubMed ID: 2427264
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The protein coded by the X-adrenoleukodystrophy gene is a peroxisomal integral membrane protein.
    Contreras M; Mosser J; Mandel JL; Aubourg P; Singh I
    FEBS Lett; 1994 May; 344(2-3):211-5. PubMed ID: 8187886
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The deficient degradation of synthetic 2- and 3-methyl-branched fatty acids in fibroblasts from patients with peroxisomal disorders.
    Van Veldhoven PP; Huang S; Eyssen HJ; Mannaerts GP
    J Inherit Metab Dis; 1993; 16(2):381-91. PubMed ID: 7692128
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adrenoleukodystrophy-related protein can compensate functionally for adrenoleukodystrophy protein deficiency (X-ALD): implications for therapy.
    Netik A; Forss-Petter S; Holzinger A; Molzer B; Unterrainer G; Berger J
    Hum Mol Genet; 1999 May; 8(5):907-13. PubMed ID: 10196381
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A mouse model for X-linked adrenoleukodystrophy.
    Lu JF; Lawler AM; Watkins PA; Powers JM; Moser AB; Moser HW; Smith KD
    Proc Natl Acad Sci U S A; 1997 Aug; 94(17):9366-71. PubMed ID: 9256488
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A novel method for determining peroxisomal fatty acid β-oxidation.
    Morita M; Matsumoto S; Okazaki A; Tomita K; Watanabe S; Kawaguchi K; Minato D; Matsuya Y; Shimozawa N; Imanaka T
    J Inherit Metab Dis; 2016 Sep; 39(5):725-731. PubMed ID: 27324171
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Measurement of peroxisomal fatty acid beta-oxidation in cultured human skin fibroblasts.
    Wanders RJ; Denis S; Ruiter JP; Schutgens RB; van Roermund CW; Jacobs BS
    J Inherit Metab Dis; 1995; 18 Suppl 1():113-24. PubMed ID: 9053546
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical variation in X-linked adrenoleukodystrophy: fatty acid and lipid metabolism in cultured fibroblasts.
    Boles DJ; Craft DA; Padgett DA; Loria RM; Rizzo WB
    Biochem Med Metab Biol; 1991 Feb; 45(1):74-91. PubMed ID: 2015112
    [TBL] [Abstract][Full Text] [Related]  

  • 34. X-linked adrenoleukodystrophy: biochemical diagnosis and enzyme defect.
    Wanders RJ; van Roermund CW; Lageweg W; Jakobs BS; Schutgens RB; Nijenhuis AA; Tager JM
    J Inherit Metab Dis; 1992; 15(4):634-44. PubMed ID: 1528022
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of the testosterone metabolite dihydrotestosterone and 5 alpha-androstan-3 alpha,17 beta-diol on very long chain fatty acid metabolism in X-adrenoleukodystrophic fibroblasts.
    Petroni A; Blasevich M; Uziel G
    Life Sci; 2003 Aug; 73(12):1567-75. PubMed ID: 12865096
    [TBL] [Abstract][Full Text] [Related]  

  • 36. X-linked adrenoleukodystrophy: improved prenatal diagnosis using both biochemical and immunological methods.
    Wanders RJ; Mooyer PW; Dekker C; Vreken P
    J Inherit Metab Dis; 1998 Jun; 21(3):285-7. PubMed ID: 9686376
    [No Abstract]   [Full Text] [Related]  

  • 37. Plasmalogen biosynthesis in the diagnosis of peroxisomal disorders.
    Kremser K; Roscher A
    J Clin Chem Clin Biochem; 1989 May; 27(5):315-7. PubMed ID: 2760566
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [X-linked adrenoleukodystrophy].
    Aubourg P
    Ann Endocrinol (Paris); 2007 Dec; 68(6):403-11. PubMed ID: 17532287
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Very long chain fatty acids in the pathogenesis, prenatal and postnatal diagnosis of X-linked adrenoleukodystrophy].
    Grković S; Dordević M; Nikolić R; Zivancević-Simonović S; Puzigaća Z
    Med Pregl; 2007; 60(7-8):401-3. PubMed ID: 17990810
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Carrier identification of X-linked adrenoleukodystrophy by measurement of very long chain fatty acids and lignoceric acid oxidation.
    Inoue K; Suzuki Y; Yajima S; Shimozawa N; Tomatsu S; Orii T; Kondo N
    Clin Genet; 1996 Nov; 50(5):348-52. PubMed ID: 9007322
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.